Related Experiment Videos
Early gastric carcinoma with special reference to macroscopic classification.
Cancer
|September 1, 1987
Summary
This study analyzed 1000 early gastric carcinoma cases from 1946-1978. Depressed early gastric carcinoma was more common, with higher lymph node metastasis rates in submucosal and elevated types, impacting survival.
Area of Science:
- Gastroenterology
- Oncology
- Surgical Pathology
Background:
- Early gastric carcinoma (EGC) diagnosis and treatment have evolved significantly.
- Understanding the characteristics of EGC is crucial for effective management.
- A large cohort study provides valuable insights into historical EGC trends.
Purpose of the Study:
- To analyze the clinical characteristics, macroscopic changes, and chronological progression of solitary early gastric carcinoma.
- To investigate the incidence, location, and age distribution of depressed versus elevated EGC types.
- To determine the relationship between invasion depth, lymph node metastasis, and survival rates in EGC.
Main Methods:
- Retrospective analysis of 1000 surgically treated solitary early gastric carcinoma cases.
- Classification of EGC into depressed and elevated types based on macroscopic appearance.
- Evaluation of invasion depth, lymph node metastasis, and 5-year survival rates.
Main Results:
- Early gastric carcinoma constituted one-third of all resected gastric carcinomas.
- Depressed type EGC was more common (1:4 ratio to elevated type) and predominantly located in the middle third of the stomach.
- Lymph node metastasis occurred in 12.7% of EGC cases, with higher rates in submucosal (21.7%) and elevated types (20.9%).
- 5-year survival rates were 93.8% for curative resection versus 56.5% for palliative resection.
Conclusions:
- Early gastric carcinoma exhibits distinct clinical and macroscopic features based on type and location.
- Lymph node metastasis is a significant prognostic factor in EGC, particularly for submucosal and elevated lesions.
- Curative surgical resection offers a high survival rate for early gastric carcinoma patients.